Asian Fund for Cancer Research Overview

420 views
291 views

Published on

The Asian Fund for Cancer Research, Ltd. (AFCR) is a non-profit organization committed to curing cancers that have significant impacts on Asian populations. Headquartered in Hong Kong, AFCR is uniquely positioned to implement in Asia the newest cancer research discoveries and technologies from around the world, investigate the distinct causes of cancer in Asian populations through innovative genetic and molecular research, and develop more effective therapies tailored to Asian cancer patients. AFCR is dedicated to bridging the scientific and educational gaps in cancer research and cancer prevention between Asian countries and the rest of the world through promoting, coordinating and funding international collaboration in cancer research and public education. We are fully devoted to reducing the incidence and increasing the survival rate of cancers in Asia. We encourage you to visit our website for more information about cancer prevention tips and our programs. http://afcr.org.hk/en

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
420
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Asian Fund for Cancer Research Overview

  1. 1. Asian Fund for Cancer Research A Hong Kong-Based, China-Focused, Worldwide Charity to Fight Cancer
  2. 2. Our Mission • The Asian Fund for Cancer Research, Limited (AFCR) is a nonprofit organization committed to curing cancers of significant impact for Asian populations. • Headquartered in Hong Kong, AFCR is uniquely positioned to implement in Asia the newest cancer research discoveries and technologies from around the world, investigate the distinct causes of cancer in Asian populations through innovative genetic and molecular research, and develop more effective therapies tailored to Asian cancer patients. • AFCR bridges the scientific and educational gaps in cancer research and cancer prevention between Asian countries and the rest of the world through promoting, coordinating and funding international collaboration in cancer research and public education. • We are devoted to reducing the incidence and increasing the survival rate of cancers in Asia.
  3. 3. Our Focus  Investigating new and more effective prevention strategies to reduce cancer incidence.  Exploring more accurate early detection and diagnostic technologies.  Discovering new anti-cancer drugs that will stop the spread of cancer.  Developing targeted molecular therapies to personalize treatment regimens for cancer patients.  Modernizing and adapting traditional Chinese medicines for cancer treatment.  Providing prevention tips and nutrition education to the general public to help reduce cancer risk.  Fostering and facilitating collaboration among scientists across institutions and regions.
  4. 4. Our Approach • Advancing Cutting-Edge Cancer Research • Building an International Network to Defeat Cancer • Creating Collaborative Platforms • Promoting Public Awareness of Cancer
  5. 5. Leadership Team  Senior Management Team • Sujuan Ba, Ph.D. President and CEO • Michael Wang, M.D., Ph.D. Chief Operating Officer • Kwok Leung, Ph.D. Chief Financial Officer  Board of Directors • Gary Gee Nung Wong, Chairman Consultant, OLN Lawyers • Kwok Fai Chan Information & Communication Manager The Family Planning Association of Hong Kong • Albert Cheung-Hoi Yu, Ph.D. Chairman & CEO, Hai Kang Life Corporation Limited Chairman, Hong Kong Biotechnology Organization
  6. 6. Scientific Advisory Board  Webster Cavenee, Ph.D., Chairman Ludwig Institute for Cancer Research  Anthony Chan, M.D. The Chinese University of Hong Kong  Yung-Chi Cheng, Ph.D. Yale University School of Medicine  Mien-Chie Hung, Ph.D. University of Texas M.D. Anderson Cancer Center  Paul Schimmel, Ph.D. Scripps Research Institute  George Tsao, Ph.D. The University of Hong Kong
  7. 7. Medical Advisory Board  Ronnie Poon, MBBS, MS, Ph.D., Chairman The University of Hong Kong and Queen Mary Hospital  Tony S. K. Mok, M.D. The Chinese University of Hong Kong  Waun Ki Hong, M.D. University of Texas M.D. Anderson Cancer Center  Edward Chu, M.D. University of Pittsburg  Wai-Kwan Alfred Yung, M.D. University of Texas MD Anderson Cancer Center  Ben Yong, M.D. Pfizer Global Research and Development
  8. 8. Key Programs of AFCR at Glimpse  Research Programs - focused on cancers that have high impact on the Asian populations     Lung cancer Esophageal cancer Ovarian cancer Colorectal cancer  International Collaborative Programs      Establishing International Research Partnership to Defeat Brain Tumor (GBM) Connecting Chinese Glioma Cooperative Group (CGCG) with Defeat GBM International Network Gastric Cancer Project at the Tissue Bank Consortium in Asia Accelerating Modernization of Traditional Chinese Medicine (TCM) Facilitating International Dialogues and Collaborations to Advance Cancer Research
  9. 9. Key Programs of AFCR at Glimpse (Cont’d) • Public Education Program  Cancer Awareness  Cancer Detection Guidelines  Prevention Tips  ―On Your Health‖ cancer-fighting guidance series  Direct Response Program    Reaching thousands of households in Hong Kong and other parts of Asia Distributing public education materials on the latest progress in cancer prevention, diagnosis and treatment Raising funds for AFCR’s leading-edge cancer research and public education programs  Digital Presence     Bilingual Website (English & Chinese) Current research and activities at AFCR Up-to-date cancer headlines & global news AFCR progress reports
  10. 10. Research Programs • Advancing Research for Asian Lung Cancer Patients:  Led by Professor Tony Mok at The Chinese University of Hong Kong.  Research on personalized lung cancer treatments for the Asian populations.  Results from this research are offering new insights into the mystery of how Asian patients with non-small cell lung cancer (NSCLC) develop resistance to targeted therapies.  Continued research can develop a promising approach to treating Asian lung cancer patients, giving them the best chance for a longer life. • Identifying Biomarkers for Early Detection of Esophageal Cancer:   Research on identifying ―biomarkers‖ that could be used to detect esophageal cancer earlier or determine those individuals who are at high risk to develop it.  • Led by Professor Maria Li Lung at The University of Hong Kong. A simple blood screening test for early detection of esophageal cancer can be the fruits of this research. Overcoming Treatment Resistance in Ovarian Cancer:  Led by Professor Wei Zhang at the MD Anderson Cancer Center, USA.  Develop a treatment that fights tumor’s resistance to standard chemotherapy that many ovarian cancer patients eventually experience.  His team of international collaborators has identified a short piece of RNA called microRNA (miRNA) that may be the key to sensitizing the tumor to chemotherapy, overcoming the problem of resistance.  With continued success, the miRNA is likely to become a potent new therapeutic tool for ovarian cancer that can overcome the drug resistance and save the lives of women with ovarian cancer.
  11. 11. Research Programs (Cont’d) • A New Tumor Suppressor Gene and Potential Treatment for Colorectal Cancer Patients:   Collaborate with Chinese scientists to confirm that the lack of a tumor suppressor gene in some Asian colorectal cancer patients may explain why their cancer has spread.  The tumor suppressor gene can serve as a prognostic indicator to help doctors choose the best treatment approach for their patients.  • Led by Professor Wei Zhang at the MD Anderson Cancer Center, USA. The tumor suppressor gene may also serve as a target for the development of new therapeutics to stop the spread of colorectal cancer. Developing Novel Therapeutic Strategies for Colorectal Cancer Patients:  Led by Dr. Roberta Pang at The University of Hong Kong.  Develop a minimally invasive blood test that will accurately determine if colorectal cancer patients are at risk for their cancer to spread, or if former patients are at risk for their cancer to return.  The test is one of the ―next-generation‖ tools that doctors could use to diagnose and treat cancer at earlier stages.
  12. 12. International Collaborative Programs
  13. 13. Establishing International Research Partnership to Defeat GBM • Initiated by AFCR and its sister organization in the U.S., the National Foundation for Cancer Research (NFCR). • A scalable, multi-investigator, multi-institutional interdisciplinary consortium focused solely on patients with Glioblastoma (GBM), the deadliest form of brain tumor. • A true international collaborative platform: China, US, UK, Germany, Brazil, Singapore and Australia. • Enabling active public-private partnership and academia-industry collaboration on brain tumor research worldwide. • Aim: to strengthen the research and expedite the translation of research outcomes into clinical applications for GBM and other types of brain tumor. • On April 5, 2013, AFCR, NFCR, the Beijing Institute for Brain Disorder (BIBD) and Beijing Neurosurgical Institute (BNI) officially signed the MOU (Memorandum of Understanding) of the international GBM collaboration program in Washington DC. • More than 40 leading cancer researchers and officials from both China and the US, including Dr. Zhu Chen, Former Chinese Minister of Health, attended the ceremony to support and witness the official launch of this highimpact collaboration program.
  14. 14. Connecting Chinese Glioma Cooperative Group (CGCG) with the Defeat GBM International Network • AFCR sent a delegation to attend the 2013 NFCR-CGCG GBM Conference co-organized by NFCR and CGCG on July 5-7, 2013 in Nanjing, China. • AFCR & NFCR connect CGCG with the Defeat GBM International Network. • AFCR & NFCR, together with the Chinese partner institutions including Beijing Tiantan Hospital, Peking Union Medical College Hospital, Beijing Shijitan Hospital, and Beijing Sanbo Hospital, organized the first meeting of the Defeat GBM Initiative to discuss the clinical trial protocol of how to conduct GBM research in China. • The first clinical trial in China testing targeted therapies for GBM will start soon.
  15. 15. TBCA Gastric Cancer Project • Working in partnership with NFCR, AFCR is actively participating in infrastructure building and research program developing for the Tissue Bank Consortium in Asia (TBCA), a collaboration platform that promotes biospecimenbased cancer research collaboration around the world. • A research project focusing on gastric cancer has been initiated . The success of this project will positively impact many areas of gastric cancer diagnosis and treatment, saving more lives from this deadly disease. AFCR is an active driving force on this high-impact research project. • On April 6, 2013, AFCR and NFCR co-hosted a roundtable meeting in Washington, DC, discussing the current progress and future direction of the TBCA Gastric Cancer Project. TBCA academic and corporate members from both China and US, including Tianjin Medical University/Institute, Amgen, Abbott Laboratories and Eli Lilly attended the meeting and presented their updates and thoughts.
  16. 16. Accelerating Modernization of Traditional Chinese Medicine (TCM)    Advancing the modernization and scientific validation of TCM. Building an International Center for TCM Research for Cancer Treatment with NFCR in the US. The Center will: • • • • Recruit top Chinese and US researchers who have expertise in TCM modernization in cancer treatment. Conduct preclinical studies using highly standardized research materials and protocols. Perform rigorously monitored clinical trials according to the internationally recognized standard, the Good Clinical Practice (ICH-GCP). Expand the recognition of TCM’s medical functions and benefits in the world and advance modernization of TCM in cancer treatment.
  17. 17. Sponsoring the 8th Annual Szent-Györgyi Prize for Progress in Cancer Research Dinner and Award Ceremony April 5, 2013 | Washington DC, USA 8th Prize Winner Dr. Alex Matter, CEO of A*Star in Singapore Dr. Sujuan Ba, 8th Prize Selection Committee Co-Chair and AFCR President 8th Prize Selection Committee Chair Dr. Zhu Chen and Co-Chair Dr. Sujuan Ba with 8th Prize Winner Dr. Alex Matter Dr. Zhu Chen, 8th Prize Selection Committee Chair, 7th Prize Co-Winner, and Former Chinese Minister of Health Keynote Speaker Mr. John Castellani, President of PhRMA Mr. Franklin Salisbury, Jr., NFCR President
  18. 18. Organizing the “Asia-US Panel Discussion on Targeted Cancer Therapies and Global Strategy for Clinical Development” April 5, 2013| Washington, D.C., USA • AFCR sponsors and organizes summit discussions among top academic researchers and industry leaders from both Asia and the US on targeted therapies and global strategy for clinical development. • Calls for a broader and more aggressive approach in both basic and clinical research collaborations between the China, US, and other Asian countries. • 40 Attendees by invitation only, comprised off cancer research leaders of academia, government and industry from Asia and US.
  19. 19. Organizing High-Level Meeting with Dr. Zhu Chen and Leaders of Chinese Cancer Research Community in Beijing July 8, 2013 | Beijing, China • AFCR leadership met with many high-profile leaders in Chinese cancer research community to discuss the framework and scope of a joint China –US Lab on GBM. The attendees included Dr. Zhu Chen, Former Chinese Minister of Health. • AFCR leadership finalized the partnership agreement with Beijing Tiantan Hospital, Capital Medical University and Beijing Neurosurgical Institute. All parties agreed to seek state approval status for the China-US Joint Lab, which will enable the lab to receive more financial resources and visibility in China. • The Steering Committee of the China-US Joint Lab was assembled., co-led by Dr. Zhu Chen and AFCR Scientific Advisory Board Chairman Dr. Webster Cavenee.
  20. 20. Public Education Program  Cancer Awareness Colors To increase public awareness of various cancers and to understand cancer at the cellular and molecular level—understanding the root causes of cancer.  Childhood Cancer Detection Chart Comprehensive information for childhood cancer detection in one chart to help parents understand the different types of cancer, such as leukemia and lymphoma, and how to detect any symptoms of those diseases in their own children.  Cancer Detection Guide To educate individuals about the latest cancer screenings and diagnostic tests for various cancers that may help detect cancer early.  “On Your Health” Series To provide cancer-fighting guidance to help people reduce their cancer risk through lifestyle and diet change.  Prevention Tips for Ovarian Cancer Detailed information about risk factors, symptoms and prevention tips for ovarian cancer, aiming to raise more awareness in women of this ―Silent Killer.‖
  21. 21. Public Education Program (Cont’d)  Skin Cancer Prevention Tips Practical skin cancer prevention guidelines to help keep people and their families skin cancer-free.  Risk Factors for Colorectal Cancer To help the general public better understand the risk factors of the disease so that they can minimize the risk through adopting healthy lifestyles and taking regular colorectal cancer screening examinations.  Breast Cancer Examination Guidance on periodic self-examination and screening that may help detect breast cancer early and save lives.  Risk Factors for Lung Cancer Providing the general public with risk factors for lung cancer and encourages people to live a healthy lifestyle, which is crucial for lung cancer prevention.  Warning Signs of Cancer Providing warning signs of a variety of cancers such as lung, breast, colorectal, prostate, uterine, ovarian, cervical, and skin cancer.  Cancer-Fighting Recipes A wide variety of healthy recipes, from traditional to new and interesting ones, to help people add more healthy foods to their daily diet.
  22. 22. Direct Response Program • Reaches thousands of households in Hong Kong and other parts of Asia. • Delivers to our donors and prospects: • • Cancer prevention tips • Cancer screening and detection guidelines • Healthy recipes, and • • The latest research updates of our programs Hope for the Cure Raises funds essential for the leading-edge and life-saving research and public education programs at AFCR.
  23. 23. Digital Presence • Continuously add new and fresh content onto the bilingual website, including cancer headlines, global news, cancer prevention tips, events, etc. • Feature key research projects and event spotlights onto the flash board. • Reach more audience through social networking sites such as Facebook and Twitter. • Send out E-newsletters on a quarterly basis, including research program highlights, events, global news, healthy tips, etc. • Send out periodic E-appeals for special announcements and event promotions.
  24. 24. Taking Action Against Cancer Coffee Wong Book Signing & Charitable Donation Event March 23, 2013 | Hong Kong, China • Mr. Eric Wong (nicknamed ―Coffee Wong‖), Former Director and General Manager of Bright Sun Coffee Co., Ltd and a dedicated supporter of AFCR, successfully hosted a book signing and charitable donation event for his new book “Enjoy Coffee, Enjoy Life” to benefit AFCR’s life-saving cancer research projects. • At the event, Coffee Wong shared his feelings and experiences of writing and publishing the book, and also had a charitable sale for his new coffee flavor ―Happy Ha Ha Ha.‖ • All the net proceeds from the event, in total HK$45,688, was donated to AFCR. • The newspaper Oriental Daily mentioned this successful event on its July 26 th issue.
  25. 25. Fighting Cancer by Working Together AFCR - Curing Cancer, Saving Lives

×